Former Google Wallet Chief Lands $100 Million for Startup Poynt
(Bloomberg) -- Poynt Co., a startup that competes with Square Inc., said it raised $100 million to take a bigger chunk out of the multitrillion-dollar payments market.
The company plans to use the new money to expand into markets in Asia, Europe and South America, as well as increase hiring. Investors in the round included Elavon, a unit of U.S. Bancorp, and National Australia Bank Ltd. Previous backers include GV, the venture capital arm of Google parent Alphabet Inc., and Matrix Partners.
Poynt was founded by Osama Bedier, the former head of Google Wallet and a digital-payments veteran. The Palo Alto, California-based firm makes payment terminals for merchants. But its main goal is to build an operating system that runs any payment terminal, and supports quick software updates and applications written by outside developers. That's similar to how Google's Android and Apple Inc.'s iOS operating systems improved phones.
“iOS and Android transformed a ubiquitous utility into a platform for innovation where developers could build once and distribute everywhere,” Bedier said in statement. “Our vision is to transform retail by becoming that innovation platform for payment terminals.”
The startup said it has shipped close to 150,000 terminals in the last 16 months and total payment volume is expected to exceed $25 billion over the next year. Poynt has partnerships with banks including JPMorgan Chase & Co., and about 8,000 developers have created apps on its operating system.
To contact the reporter on this story: Julie Verhage in New York at jverhage2@bloomberg.net
To contact the editors responsible for this story: Mark Milian at mmilian@bloomberg.net, Alistair Barr, Andrew Pollack
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.